Dibrompropamidine PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
496-00-4
Molecular formula
C17H18Br2N4O2
Molecular weight
470.2 g/mol
Drug class
Diamidine antiseptictopical antibacterial agent
Mechanism of action
Exerts local antimicrobial activity through interaction with microbial nucleic acids and cellular structures; the precise mechanism in ocular pathogens is not fully characterised.
Indications / reported uses
Topical ophthalmic treatment of superficial bacterial eye infections such as conjunctivitis and blepharitis in countries where dibrompropamidine isetionate products are authorised
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Dibrompropamidine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Dibrompropamidine Permitted Daily Exposure (PDE) report (the Dibrompropamidine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Dibrompropamidine Occupational Exposure Limit (OEL) report (the Dibrompropamidine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.